Rachlin Evan Lockwood insider trades
Rachlin Evan Lockwood has filed 2 Form 4s with the SEC that we hold, all for Iambic Therapeutics, Inc. (IAM), as Director. Across all of them we count 1 purchase worth $11.5M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($11.5M) and 0 sales ($0). The largest single trade was a purchase of 718,750 shares of Iambic Therapeutics, Inc. worth $11.5M, dated 2026-10-16. The first filing on our record is dated 2026-10-16 and the latest 2026-10-19.
Iambic Therapeutics, Inc. (IAM)
Director · 2 filings · 1 purchase or sale
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-16 | P, purchase reported on Form 4 | 718,750 | $11.5M | 2026-10-19 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 2151678) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
